Journal
JAMA NEUROLOGY
Volume 72, Issue 11, Pages 1361-1366Publisher
AMER MEDICAL ASSOC
DOI: 10.1001/jamaneurol.2015.1921
Keywords
-
Categories
Funding
- National Institutes of Health [1U01MH105892-01]
Ask authors/readers for more resources
Neurologic disorders are frequently a result of inappropriate electrical and/or chemical signaling of neurons and glia. Ultimate remediation would necessitate reprogramming these signals. Historically, correcting neuronal and glial signaling is accomplished via drug therapy/administration, although they frequently fail to effectively and fully treat the underlying disorder. Developments in basic research have produced several new classes of potential therapeutics to directly and precisely control neuron activity at the single-cell level. We review one such technology, Designer Receptors Exclusively Activated by Designer Drugs, and suggest its potential as a powerful tool for augmenting neuronal and glial signaling and activity for basic and translational applications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available